Table 3.
Odds of LVI for lymph node metastasis analyzed by multivariate logistic regression
| Univariate | Multivariate | ||||
|---|---|---|---|---|---|
| p-value | OR | 95% CI | p-value | ||
| PSA (ng/mL) | ≥20 | <0.001* | 3.208 | 1.647-6.246 | 0.001* |
| Pathologic T stage | ≥3 | <0.001* | 2.216 | 0.722-6.803 | 0.165 |
| Pathologic Gleason score | ≥8 | <0.001* | 5.745 | 2.687-12.285 | <0.001* |
| PSM | <0.001* | 3.697 | 1.462-9.351 | 0.006* | |
| LVI | <0.001* | 4.317 | 2.092-8.910 | <0.001* |
LVI lymphovascular invasion; PSM positivie surgical margin; PSA prostate-specific antigen;OR odds ratio;CI confidence interval